Cardiff Oncology
CRDF
25 hedge funds and large institutions have $26.4M invested in Cardiff Oncology in 2013 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.
489% more capital invested
Capital invested by funds: $4.49M → $26.4M (+$21.9M)
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
56% more funds holding
Funds holding: 16 → 25 (+9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BM
Bridger Management
New York
|
+$16.9M |
| 2 |
Morgan Stanley
New York
|
+$2.29M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.05M |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$1.02M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$643K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$80.3K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$30K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$569 |
CRDF Hedge Fund Activity: Q3 2013 in Review
25 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q3 2013, worth a combined $26.4M — up 489% from $4.49M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CRDF positions and 2 closed out — a net gain of 9 holders — while 8 added to existing stakes and 2 trimmed.
The largest buyer was Bridger Management, opening a new position worth an estimated $16.9M. The largest seller was Wells Fargo, cutting an estimated $80.3K.
- 25 institutional investors held Cardiff Oncology (CRDF) as of Q3 2013, up from 16 in Q2 2013.
- Funds reported $26.4M of Cardiff Oncology stock for Q3 2013, up 489% quarter-over-quarter.
- 11 funds opened new Cardiff Oncology positions in Q3 2013 and 2 closed out, a net change of +9 holders.
- The largest Cardiff Oncology buyer in Q3 2013 was Bridger Management, an estimated $16.9M added.
- The largest Cardiff Oncology seller in Q3 2013 was Wells Fargo, an estimated $80.3K sold.
Based on aggregated 13F filings for Q3 2013.